Personalized Health Project: An Action Summit for LIfe Science Leaders
The Personalized Health Project and video was sponsored by the Ewing Marion Kauffman Foundation.
"Can the wellness movement fuse with the new biology?"
Dean Ornish, MD, Founder and President, Preventative Medicine Research Institute, Clinical Professor of Medicine, UCSF
Sue Seigel, Mohr Davidow Ventures
Paul Billings, MD, PhD, CMO, Life Technologies
Alexandra Drane, President and Co-Founder, Eliza Corporation
Moderator: Thomas Goetz, Executive Editor, Wired Magazine
"Playing in the Same Sandbox": David Ewing Duncan
Brief Presentation of a Great Idea, Project or Protocol
Anthony Atala, MD, board member, Regenerative Medicine Foundation; Director, Wake Forest Institute for Regenerative Medicine (by Skype)
An overview of the technologies that will create a personalized health future, Daniel Kraft, MD, Stanford Medical Center and Singularity University
Anthony Atala is Director of the Wake Forest Institute for Regenerative Medicine and Chair of Urology at the Wake Forest University School of Medicine. Dr. Atala is a surgeon, researcher and expert on regenerative medicine and stem cells.
His current work focuses on growing new human cells, tissues and organs (including kidney, blood vessels, cartilage, bladder and pancreas). Ten applications of his technologies have been used clinically. Dr. Atala has received numerous awards, including the Christopher Columbus Foundation Award bestowed on an American working on a discovery that will significantly affect society.
He was named by Scientific American as a Medical Treatments Leader of the Year and by Fast Company as one of 50 people who "will change how we work and live over the next 10 years." He is the editor of numerous journals and books, has published more than 300 journal articles and book chapters, and has applied for or received more than 200 patents.
Paul Billings, MD, PhD, is CMO of Life Technologies.
Jason Bobe is the founding Executive Director of PersonalGenomes.org and has served as the Director of Community for the Harvard Personal Genome Project since 2007. Jason is also curator and executive producer of the annual Genomes, Environments and Traits Conference. He was an invited speaker to the Presidential Commission for the Study of Bioethical Issues and is a regular commentator on the importance of citizen science, decentralized access to genomic technologies and DIYbio. Twitter: @jasonbobe
George Church, PhD is Professor of Genetics, Harvard Medical School, Wyss Institute, Director of the Center for Computational Genetics, Director of the NIH Center for Excellence in Genomic Science (on human genome engineering), founder of PGP and guinea PiG#1. He is a member of the NAS and NAE and Franklin Laureate for Achievement in Science.
Lisa Conte, CEO, Napo Pharmaceuticals
Alexandra Drane is the founder and president of the Eliza Corporation. Drane has devoted her career to inspiring people to lead healthier, happier and more engaged lives through the use of innovative technology. Her entrepreneurial spirit and passion for technology and design have led to the launch of four successful healthcare ventures over the past 15 years.
Prior to founding Eliza, Alexandra was a founder of three other healthcare ventures -- all focused on developing products that enable individual behavior change through the use of technology.
She has been named to the Boston Business Journal's "40 Under 40" list and also appears on the Healthspottr Future Health 100 list, which includes some of the most creative and influential people working in healthcare today.
David Ewing Duncan
David Ewing Duncan is an award-winning, best-selling author of eight books published in 21 languages. He is a founder and co-curator of Arc Programs. David is a columnist for Newsweek, a correspondent for The Atlantic and the chief correspondent for NPR Talk’s Biotech Nation. David writes for The New York Times, Fortune, Wired, National Geographic, Discover and many other publications. He is a former commentator for NPR’s Morning Edition and a special correspondent and producer for ABC’s Nightline and 20/20, and correspondent for NOVA’s ScienceNow!. His latest book is When I’m 164: The new science of radical life extension, and what happens if it succeeds. He also wrote Experimental Man: What One Man’s Body Reveals about His Future, Your Health, and Our Toxic World (Wiley). He was the founder and director of the BioAgenda Institute, and the founding director of the Center of Life Science Policy at UC Berkeley. David is finishing his first novel, a biomedical thriller. David’s work has won numerous awards, including Magazine Story of the Year from the American Association for the Advancement of Science. His articles have twice been cited in nominations for National Magazine Awards, and his work has appeared twice in The Best American Science and Nature Writing. David lives in San Francisco and is a member of the SF Writer’s Grotto. His website is www.davidewingduncan.com.
Sir Richard Feachem
Richard G A Feachem is Professor of Global Health at both the University of California, San Francisco and the University of California, Berkeley, and Director of the Global Health Group at UCSF Global Health Sciences.
He is also a Visiting Professor at London University and an Honorary Professor at the University of Queensland.
James Heywood is the Co-Founder and Chairman of Patients Like Me.
Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 20 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has chaired the Medicine Track for Singularity University since SU’s inception, and founded and is Executive Director of Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.
Fred Lee, MD, CMO of P4 Institute
Larry Leisure, Kleiner Perkins Caufield and Byers
Native of Dallas, graduate of UT Austin, Dean earned his M.D. from Baylor and is one of the leading progenitors of the lifestyle-driven approach to the control of chronic diseases like coronary artery disease. Through clinical research studies, he proved that comprehensive lifestyle changes could not only stop the progression of heart disease, but reverse it — and indeed, un-do a great deal of underlying system damage to restore wellness. The author or co-author of more than a dozen books and recipient of numerous major awards and accolades, Dean is a major force in transforming healthcare via patient-centered, integrative approaches.
Sue Siegel is a GE Corporate Officer and the CEO of healthymagination, GE's $6 billion global commitment to provide better health for more people by lowering costs and increasing access.
Sue is a 25-year industry leader with corporate and venture capital experience in growing companies that bring key enabling technologies to the forefront of biomedical research and healthcare. Prior to joining GE, she was a General Partner at Mohr Davidow Ventures where she led investments spanning enabling technology platforms, molecular diagnostics and digital health, which leveraged the convergence of these disciplines in driving personalized, consumer-driven and information-based healthcare.
Martyn Smith, PhD, School of Public Health, UC Berkeley, The Exposome Project
Michael Stebbins, PhD, Office of Science and Technology Policy, The White House